A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors

NCT06413953 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: TQB3107 Tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.